You are here

  • Home
  • Archive
  • Volume 30, Issue 4
  • Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021

Citation Tools

Article menu
Download PDFPDF
Original research
Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ossato A, Tessari R, Trabucchi C, et al
Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021
European Journal of Hospital Pharmacy 2023;30:e15.